ClinicalTrials.Veeva

Menu
I

INSARES | Mendoza, Argentina

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Nintedanib
BI 1015550
Verekitug
Mannitol
UPB-101
Astegolimab
EDP-938
Fluticasone Propionate
Povorcitinib
Bexotegrast

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 18 total trials

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast (FIBRONEER™-ON)

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have c...

Active, not recruiting
Progressive Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Drug: Nerandomilast

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting
Severe Asthma
Drug: Verekitug
Drug: Placebo

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Active, not recruiting
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic m...

Active, not recruiting
Asthma
Drug: TEV-56248
Drug: Albuterol sulfate

This study is open to adults with fibrosing interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF). People can join the study...

Enrolling
Interstitial Lung Diseases
Drug: Placebo matching nerandomilast
Drug: Nerandomilast

Trial sponsors

Boehringer Ingelheim logo
S
U
Enanta Pharmaceuticals logo
Genentech logo
Incyte logo
P
C
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems